SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3zl4'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ZZR_A_H4BA760_1 (NITRIC-OXIDE SYNTHASE, BRAIN)	3zl4	A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN (Homo sapiens)	4 / 7	VAL L 108 ARG L 62 VAL L 18 GLU L 84	None	1.05A	1zzrA-3zl4L: undetectable 1zzrB-3zl4L: undetectable	1zzrA-3zl4L: 19.63 1zzrB-3zl4L: 19.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ZZR_B_H4BB761_1 (NITRIC-OXIDE SYNTHASE, BRAIN)	3zl4	A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN (Homo sapiens)	4 / 7	GLU L 84 VAL L 108 ARG L 62 VAL L 18	None	1.07A	1zzrA-3zl4L: undetectable 1zzrB-3zl4L: undetectable	1zzrA-3zl4L: 19.63 1zzrB-3zl4L: 19.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ZZU_A_H4BA760_1 (NITRIC-OXIDE SYNTHASE, BRAIN)	3zl4	A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN (Homo sapiens)	4 / 7	VAL L 108 ARG L 62 VAL L 18 GLU L 84	None	1.05A	1zzuA-3zl4L: undetectable 1zzuB-3zl4L: undetectable	1zzuA-3zl4L: 19.63 1zzuB-3zl4L: 19.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ZZU_B_H4BB761_1 (NITRIC-OXIDE SYNTHASE, BRAIN)	3zl4	A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN (Homo sapiens)	4 / 7	GLU L 84 VAL L 108 ARG L 62 VAL L 18	None	1.04A	1zzuA-3zl4L: undetectable 1zzuB-3zl4L: undetectable	1zzuA-3zl4L: 19.63 1zzuB-3zl4L: 19.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2NV4_A_SAMA201_0 (UPF0066 PROTEIN AF_0241)	3zl4	A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN (Homo sapiens)	5 / 12	ASP L 86 LYS L 105 PRO L 7 GLY L 101 LEU L 4	None	1.34A	2nv4A-3zl4L: undetectable	2nv4A-3zl4L: 21.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2WEY_B_EV1B1771_1 (CAMP AND CAMP-INHIBITED CGMP 3', 5'-CYCLIC PHOSPHODIESTERASE)	3zl4	A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN (Homo sapiens)	4 / 8	LEU L 40 VAL L 108 ILE L 76 PHE L 63	None	0.95A	2weyB-3zl4L: undetectable	2weyB-3zl4L: 18.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DQR_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	3zl4	A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN (Homo sapiens)	4 / 7	VAL L 108 ARG L 62 VAL L 18 GLU L 84	None	1.06A	3dqrA-3zl4L: undetectable 3dqrB-3zl4L: undetectable	3dqrA-3zl4L: 19.53 3dqrB-3zl4L: 19.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DQR_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	3zl4	A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN (Homo sapiens)	4 / 7	GLU L 84 VAL L 108 ARG L 62 VAL L 18	None	1.09A	3dqrA-3zl4L: undetectable 3dqrB-3zl4L: undetectable	3dqrA-3zl4L: 19.53 3dqrB-3zl4L: 19.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JX2_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	3zl4	A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN (Homo sapiens)	4 / 7	VAL L 108 ARG L 62 VAL L 18 GLU L 84	None	1.02A	3jx2A-3zl4L: undetectable 3jx2B-3zl4L: undetectable	3jx2A-3zl4L: 19.53 3jx2B-3zl4L: 19.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JX2_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	3zl4	A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN (Homo sapiens)	4 / 7	GLU L 84 VAL L 108 ARG L 62 VAL L 18	None	1.03A	3jx2A-3zl4L: undetectable 3jx2B-3zl4L: undetectable	3jx2A-3zl4L: 19.53 3jx2B-3zl4L: 19.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JX3_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	3zl4	A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN (Homo sapiens)	4 / 7	VAL L 108 ARG L 62 VAL L 18 GLU L 84	None	1.07A	3jx3A-3zl4L: undetectable 3jx3B-3zl4L: undetectable	3jx3A-3zl4L: 19.53 3jx3B-3zl4L: 19.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JX3_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	3zl4	A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN (Homo sapiens)	4 / 7	GLU L 84 VAL L 108 ARG L 62 VAL L 18	None	1.01A	3jx3A-3zl4L: undetectable 3jx3B-3zl4L: undetectable	3jx3A-3zl4L: 19.53 3jx3B-3zl4L: 19.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JX4_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	3zl4	A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN (Homo sapiens)	4 / 7	GLU L 84 VAL L 108 ARG L 62 VAL L 18	None	1.04A	3jx4A-3zl4L: undetectable 3jx4B-3zl4L: undetectable	3jx4A-3zl4L: 19.53 3jx4B-3zl4L: 19.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JX5_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	3zl4	A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN (Homo sapiens)	4 / 7	VAL L 108 ARG L 62 VAL L 18 GLU L 84	None	1.04A	3jx5A-3zl4L: undetectable 3jx5B-3zl4L: undetectable	3jx5A-3zl4L: 19.53 3jx5B-3zl4L: 19.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JX5_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	3zl4	A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN (Homo sapiens)	4 / 7	GLU L 84 VAL L 108 ARG L 62 VAL L 18	None	1.02A	3jx5A-3zl4L: undetectable 3jx5B-3zl4L: undetectable	3jx5A-3zl4L: 19.53 3jx5B-3zl4L: 19.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JX6_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	3zl4	A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN (Homo sapiens)	4 / 7	VAL L 108 ARG L 62 VAL L 18 GLU L 84	None	0.97A	3jx6A-3zl4L: undetectable 3jx6B-3zl4L: undetectable	3jx6A-3zl4L: 19.53 3jx6B-3zl4L: 19.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JX6_B_H4BB761_1 (NITRIC OXIDE SYNTHASE, BRAIN)	3zl4	A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN (Homo sapiens)	4 / 7	GLU L 84 VAL L 108 ARG L 62 VAL L 18	None	0.99A	3jx6A-3zl4L: undetectable 3jx6B-3zl4L: undetectable	3jx6A-3zl4L: 19.53 3jx6B-3zl4L: 19.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NLJ_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	3zl4	A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN (Homo sapiens)	4 / 7	VAL L 108 ARG L 62 VAL L 18 GLU L 84	None	0.98A	3nljA-3zl4L: undetectable 3nljB-3zl4L: undetectable	3nljA-3zl4L: 19.53 3nljB-3zl4L: 19.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NLJ_B_H4BB761_1 (NITRIC OXIDE SYNTHASE, BRAIN)	3zl4	A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN (Homo sapiens)	4 / 7	GLU L 84 VAL L 108 ARG L 62 VAL L 18	None	0.98A	3nljA-3zl4L: undetectable 3nljB-3zl4L: undetectable	3nljA-3zl4L: 19.53 3nljB-3zl4L: 19.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NLP_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	3zl4	A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN (Homo sapiens)	4 / 7	VAL L 108 ARG L 62 VAL L 18 GLU L 84	None	1.01A	3nlpA-3zl4L: undetectable 3nlpB-3zl4L: undetectable	3nlpA-3zl4L: 19.53 3nlpB-3zl4L: 19.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NLP_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	3zl4	A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN (Homo sapiens)	4 / 7	GLU L 84 VAL L 108 ARG L 62 VAL L 18	None	1.03A	3nlpA-3zl4L: undetectable 3nlpB-3zl4L: undetectable	3nlpA-3zl4L: 19.53 3nlpB-3zl4L: 19.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NLQ_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	3zl4	A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN (Homo sapiens)	4 / 8	VAL L 108 ARG L 62 VAL L 18 GLU L 84	None	1.00A	3nlqA-3zl4L: undetectable 3nlqB-3zl4L: undetectable	3nlqA-3zl4L: 19.53 3nlqB-3zl4L: 19.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NLQ_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	3zl4	A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN (Homo sapiens)	4 / 7	GLU L 84 VAL L 108 ARG L 62 VAL L 18	None	1.01A	3nlqA-3zl4L: undetectable 3nlqB-3zl4L: undetectable	3nlqA-3zl4L: 19.53 3nlqB-3zl4L: 19.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NLR_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	3zl4	A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN (Homo sapiens)	4 / 7	VAL L 108 ARG L 62 VAL L 18 GLU L 84	None	0.99A	3nlrA-3zl4L: undetectable 3nlrB-3zl4L: undetectable	3nlrA-3zl4L: 19.53 3nlrB-3zl4L: 19.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NLR_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	3zl4	A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN (Homo sapiens)	4 / 8	GLU L 84 VAL L 108 ARG L 62 VAL L 18	None	1.03A	3nlrA-3zl4L: undetectable 3nlrB-3zl4L: undetectable	3nlrA-3zl4L: 19.53 3nlrB-3zl4L: 19.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4CX3_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	3zl4	A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN (Homo sapiens)	4 / 7	VAL L 108 ARG L 62 VAL L 18 GLU L 84	None	1.05A	4cx3A-3zl4L: undetectable 4cx3B-3zl4L: undetectable	4cx3A-3zl4L: 19.53 4cx3B-3zl4L: 19.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4CX3_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	3zl4	A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN (Homo sapiens)	4 / 7	GLU L 84 VAL L 108 ARG L 62 VAL L 18	None	1.03A	4cx3A-3zl4L: undetectable 4cx3B-3zl4L: undetectable	4cx3A-3zl4L: 19.53 4cx3B-3zl4L: 19.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4CX4_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	3zl4	A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN (Homo sapiens)	4 / 7	VAL L 108 ARG L 62 VAL L 18 GLU L 84	None	1.07A	4cx4A-3zl4L: undetectable 4cx4B-3zl4L: undetectable	4cx4A-3zl4L: 19.53 4cx4B-3zl4L: 19.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4CX4_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	3zl4	A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN (Homo sapiens)	4 / 7	GLU L 84 VAL L 108 ARG L 62 VAL L 18	None	1.03A	4cx4A-3zl4L: undetectable 4cx4B-3zl4L: undetectable	4cx4A-3zl4L: 19.53 4cx4B-3zl4L: 19.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4IKL_B_SUZB201_1 (TRANSTHYRETIN)	3zl4	A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN (Homo sapiens)	4 / 8	SER L 21 SER L 23 SER L 71 THR L 73	None	0.69A	4iklA-3zl4L: undetectable 4iklB-3zl4L: undetectable	4iklA-3zl4L: 24.77 4iklB-3zl4L: 24.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5ACL_A_SASA1111_1 (MCG)	3zl4	A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN (Homo sapiens)	4 / 7	TYR L 33 SER L 35 TYR L 37 PRO L 56	None MES L1217 ( 3.9A) None None	1.07A	5aclA-3zl4L: 21.1	5aclA-3zl4L: 66.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5ACL_A_SASA1111_1 (MCG)	3zl4	A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN (Homo sapiens)	4 / 7	TYR L 33 TYR L 37 TYR L 50 PRO L 56	None	0.76A	5aclA-3zl4L: 21.1	5aclA-3zl4L: 66.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ADD_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	3zl4	A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN (Homo sapiens)	4 / 7	GLU L 84 VAL L 108 ARG L 62 VAL L 18	None	0.99A	5addA-3zl4L: undetectable 5addB-3zl4L: undetectable	5addA-3zl4L: 19.53 5addB-3zl4L: 19.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ADE_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	3zl4	A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN (Homo sapiens)	4 / 7	GLU L 84 VAL L 108 ARG L 62 VAL L 18	None	0.96A	5adeA-3zl4L: undetectable 5adeB-3zl4L: undetectable	5adeA-3zl4L: 19.53 5adeB-3zl4L: 19.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5ALB_L_TIQL1210_2 (MEDI2452 LIGHT CHAIN)	3zl4	A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN (Homo sapiens)	4 / 8	SER L 35 TYR L 37 GLY L 90 PHE L 100	MES L1217 ( 3.9A) None None MES L1217 ( 4.9A)	0.48A	5albL-3zl4L: 20.5	5albL-3zl4L: 93.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5ALC_L_TIQL1210_2 (ANTI-TICAGRELOR FAB 72, LIGHT CHAIN)	3zl4	A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN (Homo sapiens)	4 / 8	SER L 35 TYR L 37 GLY L 90 PHE L 100	MES L1217 ( 3.9A) None None MES L1217 ( 4.9A)	0.55A	5alcL-3zl4L: 26.4	5alcL-3zl4L: 94.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5G0P_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	3zl4	A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN (Homo sapiens)	4 / 7	VAL L 108 ARG L 62 VAL L 18 GLU L 84	None	1.02A	5g0pA-3zl4L: undetectable 5g0pB-3zl4L: undetectable	5g0pA-3zl4L: 19.53 5g0pB-3zl4L: 19.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5G0P_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	3zl4	A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN (Homo sapiens)	4 / 7	GLU L 84 VAL L 108 ARG L 62 VAL L 18	None	1.02A	5g0pA-3zl4L: undetectable 5g0pB-3zl4L: undetectable	5g0pA-3zl4L: 19.53 5g0pB-3zl4L: 19.53

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1ZZR_A_H4BA760_1","NITRIC-OXIDE SYNTHASE, BRAIN;NITRIC-OXIDE SYNTHASE, BRAIN","3zl4","A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN","Homo sapiens",4,"VAL L 108;ARG L  62;VAL L  18;GLU L  84","None","1.05A","1zzrA-3zl4L:undetectable;1zzrB-3zl4L:undetectable","1zzrA-3zl4L:19.63;1zzrB-3zl4L:19.63"],["1ZZR_B_H4BB761_1","NITRIC-OXIDE SYNTHASE, BRAIN;NITRIC-OXIDE SYNTHASE, BRAIN","3zl4","A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN","Homo sapiens",4,"GLU L  84;VAL L 108;ARG L  62;VAL L  18","None","1.07A","1zzrA-3zl4L:undetectable;1zzrB-3zl4L:undetectable","1zzrA-3zl4L:19.63;1zzrB-3zl4L:19.63"],["1ZZU_A_H4BA760_1","NITRIC-OXIDE SYNTHASE, BRAIN;NITRIC-OXIDE SYNTHASE, BRAIN","3zl4","A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN","Homo sapiens",4,"VAL L 108;ARG L  62;VAL L  18;GLU L  84","None","1.05A","1zzuA-3zl4L:undetectable;1zzuB-3zl4L:undetectable","1zzuA-3zl4L:19.63;1zzuB-3zl4L:19.63"],["1ZZU_B_H4BB761_1","NITRIC-OXIDE SYNTHASE, BRAIN;NITRIC-OXIDE SYNTHASE, BRAIN","3zl4","A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN","Homo sapiens",4,"GLU L  84;VAL L 108;ARG L  62;VAL L  18","None","1.04A","1zzuA-3zl4L:undetectable;1zzuB-3zl4L:undetectable","1zzuA-3zl4L:19.63;1zzuB-3zl4L:19.63"],["2NV4_A_SAMA201_0","UPF0066 PROTEIN AF_0241","3zl4","A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN","Homo sapiens",5,"ASP L  86;LYS L 105;PRO L   7;GLY L 101;LEU L   4","None","1.34A","2nv4A-3zl4L:undetectable","2nv4A-3zl4L:21.48"],["2WEY_B_EV1B1771_1","CAMP AND CAMP-INHIBITED CGMP 3', 5'-CYCLIC PHOSPHODIESTERASE","3zl4","A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN","Homo sapiens",4,"LEU L  40;VAL L 108;ILE L  76;PHE L  63","None","0.95A","2weyB-3zl4L:undetectable","2weyB-3zl4L:18.59"],["3DQR_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","3zl4","A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN","Homo sapiens",4,"VAL L 108;ARG L  62;VAL L  18;GLU L  84","None","1.06A","3dqrA-3zl4L:undetectable;3dqrB-3zl4L:undetectable","3dqrA-3zl4L:19.53;3dqrB-3zl4L:19.53"],["3DQR_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","3zl4","A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN","Homo sapiens",4,"GLU L  84;VAL L 108;ARG L  62;VAL L  18","None","1.09A","3dqrA-3zl4L:undetectable;3dqrB-3zl4L:undetectable","3dqrA-3zl4L:19.53;3dqrB-3zl4L:19.53"],["3JX2_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","3zl4","A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN","Homo sapiens",4,"VAL L 108;ARG L  62;VAL L  18;GLU L  84","None","1.02A","3jx2A-3zl4L:undetectable;3jx2B-3zl4L:undetectable","3jx2A-3zl4L:19.53;3jx2B-3zl4L:19.53"],["3JX2_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","3zl4","A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN","Homo sapiens",4,"GLU L  84;VAL L 108;ARG L  62;VAL L  18","None","1.03A","3jx2A-3zl4L:undetectable;3jx2B-3zl4L:undetectable","3jx2A-3zl4L:19.53;3jx2B-3zl4L:19.53"],["3JX3_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","3zl4","A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN","Homo sapiens",4,"VAL L 108;ARG L  62;VAL L  18;GLU L  84","None","1.07A","3jx3A-3zl4L:undetectable;3jx3B-3zl4L:undetectable","3jx3A-3zl4L:19.53;3jx3B-3zl4L:19.53"],["3JX3_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","3zl4","A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN","Homo sapiens",4,"GLU L  84;VAL L 108;ARG L  62;VAL L  18","None","1.01A","3jx3A-3zl4L:undetectable;3jx3B-3zl4L:undetectable","3jx3A-3zl4L:19.53;3jx3B-3zl4L:19.53"],["3JX4_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","3zl4","A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN","Homo sapiens",4,"GLU L  84;VAL L 108;ARG L  62;VAL L  18","None","1.04A","3jx4A-3zl4L:undetectable;3jx4B-3zl4L:undetectable","3jx4A-3zl4L:19.53;3jx4B-3zl4L:19.53"],["3JX5_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","3zl4","A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN","Homo sapiens",4,"VAL L 108;ARG L  62;VAL L  18;GLU L  84","None","1.04A","3jx5A-3zl4L:undetectable;3jx5B-3zl4L:undetectable","3jx5A-3zl4L:19.53;3jx5B-3zl4L:19.53"],["3JX5_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","3zl4","A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN","Homo sapiens",4,"GLU L  84;VAL L 108;ARG L  62;VAL L  18","None","1.02A","3jx5A-3zl4L:undetectable;3jx5B-3zl4L:undetectable","3jx5A-3zl4L:19.53;3jx5B-3zl4L:19.53"],["3JX6_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","3zl4","A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN","Homo sapiens",4,"VAL L 108;ARG L  62;VAL L  18;GLU L  84","None","0.97A","3jx6A-3zl4L:undetectable;3jx6B-3zl4L:undetectable","3jx6A-3zl4L:19.53;3jx6B-3zl4L:19.53"],["3JX6_B_H4BB761_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","3zl4","A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN","Homo sapiens",4,"GLU L  84;VAL L 108;ARG L  62;VAL L  18","None","0.99A","3jx6A-3zl4L:undetectable;3jx6B-3zl4L:undetectable","3jx6A-3zl4L:19.53;3jx6B-3zl4L:19.53"],["3NLJ_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","3zl4","A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN","Homo sapiens",4,"VAL L 108;ARG L  62;VAL L  18;GLU L  84","None","0.98A","3nljA-3zl4L:undetectable;3nljB-3zl4L:undetectable","3nljA-3zl4L:19.53;3nljB-3zl4L:19.53"],["3NLJ_B_H4BB761_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","3zl4","A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN","Homo sapiens",4,"GLU L  84;VAL L 108;ARG L  62;VAL L  18","None","0.98A","3nljA-3zl4L:undetectable;3nljB-3zl4L:undetectable","3nljA-3zl4L:19.53;3nljB-3zl4L:19.53"],["3NLP_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","3zl4","A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN","Homo sapiens",4,"VAL L 108;ARG L  62;VAL L  18;GLU L  84","None","1.01A","3nlpA-3zl4L:undetectable;3nlpB-3zl4L:undetectable","3nlpA-3zl4L:19.53;3nlpB-3zl4L:19.53"],["3NLP_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","3zl4","A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN","Homo sapiens",4,"GLU L  84;VAL L 108;ARG L  62;VAL L  18","None","1.03A","3nlpA-3zl4L:undetectable;3nlpB-3zl4L:undetectable","3nlpA-3zl4L:19.53;3nlpB-3zl4L:19.53"],["3NLQ_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","3zl4","A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN","Homo sapiens",4,"VAL L 108;ARG L  62;VAL L  18;GLU L  84","None","1.00A","3nlqA-3zl4L:undetectable;3nlqB-3zl4L:undetectable","3nlqA-3zl4L:19.53;3nlqB-3zl4L:19.53"],["3NLQ_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","3zl4","A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN","Homo sapiens",4,"GLU L  84;VAL L 108;ARG L  62;VAL L  18","None","1.01A","3nlqA-3zl4L:undetectable;3nlqB-3zl4L:undetectable","3nlqA-3zl4L:19.53;3nlqB-3zl4L:19.53"],["3NLR_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","3zl4","A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN","Homo sapiens",4,"VAL L 108;ARG L  62;VAL L  18;GLU L  84","None","0.99A","3nlrA-3zl4L:undetectable;3nlrB-3zl4L:undetectable","3nlrA-3zl4L:19.53;3nlrB-3zl4L:19.53"],["3NLR_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","3zl4","A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN","Homo sapiens",4,"GLU L  84;VAL L 108;ARG L  62;VAL L  18","None","1.03A","3nlrA-3zl4L:undetectable;3nlrB-3zl4L:undetectable","3nlrA-3zl4L:19.53;3nlrB-3zl4L:19.53"],["4CX3_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","3zl4","A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN","Homo sapiens",4,"VAL L 108;ARG L  62;VAL L  18;GLU L  84","None","1.05A","4cx3A-3zl4L:undetectable;4cx3B-3zl4L:undetectable","4cx3A-3zl4L:19.53;4cx3B-3zl4L:19.53"],["4CX3_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","3zl4","A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN","Homo sapiens",4,"GLU L  84;VAL L 108;ARG L  62;VAL L  18","None","1.03A","4cx3A-3zl4L:undetectable;4cx3B-3zl4L:undetectable","4cx3A-3zl4L:19.53;4cx3B-3zl4L:19.53"],["4CX4_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","3zl4","A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN","Homo sapiens",4,"VAL L 108;ARG L  62;VAL L  18;GLU L  84","None","1.07A","4cx4A-3zl4L:undetectable;4cx4B-3zl4L:undetectable","4cx4A-3zl4L:19.53;4cx4B-3zl4L:19.53"],["4CX4_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","3zl4","A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN","Homo sapiens",4,"GLU L  84;VAL L 108;ARG L  62;VAL L  18","None","1.03A","4cx4A-3zl4L:undetectable;4cx4B-3zl4L:undetectable","4cx4A-3zl4L:19.53;4cx4B-3zl4L:19.53"],["4IKL_B_SUZB201_1","TRANSTHYRETIN;TRANSTHYRETIN","3zl4","A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN","Homo sapiens",4,"SER L  21;SER L  23;SER L  71;THR L  73","None","0.69A","4iklA-3zl4L:undetectable;4iklB-3zl4L:undetectable","4iklA-3zl4L:24.77;4iklB-3zl4L:24.77"],["5ACL_A_SASA1111_1","MCG","3zl4","A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN","Homo sapiens",4,"TYR L  33;SER L  35;TYR L  37;PRO L  56","None;MES L1217 ( 3.9A);None;None","1.07A","5aclA-3zl4L:21.1","5aclA-3zl4L:66.36"],["5ACL_A_SASA1111_1","MCG","3zl4","A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN","Homo sapiens",4,"TYR L  33;TYR L  37;TYR L  50;PRO L  56","None","0.76A","5aclA-3zl4L:21.1","5aclA-3zl4L:66.36"],["5ADD_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","3zl4","A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN","Homo sapiens",4,"GLU L  84;VAL L 108;ARG L  62;VAL L  18","None","0.99A","5addA-3zl4L:undetectable;5addB-3zl4L:undetectable","5addA-3zl4L:19.53;5addB-3zl4L:19.53"],["5ADE_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","3zl4","A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN","Homo sapiens",4,"GLU L  84;VAL L 108;ARG L  62;VAL L  18","None","0.96A","5adeA-3zl4L:undetectable;5adeB-3zl4L:undetectable","5adeA-3zl4L:19.53;5adeB-3zl4L:19.53"],["5ALB_L_TIQL1210_2","MEDI2452 LIGHT CHAIN","3zl4","A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN","Homo sapiens",4,"SER L  35;TYR L  37;GLY L  90;PHE L 100","MES L1217 ( 3.9A);None;None;MES L1217 ( 4.9A)","0.48A","5albL-3zl4L:20.5","5albL-3zl4L:93.52"],["5ALC_L_TIQL1210_2","ANTI-TICAGRELOR FAB 72, LIGHT CHAIN","3zl4","A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN","Homo sapiens",4,"SER L  35;TYR L  37;GLY L  90;PHE L 100","MES L1217 ( 3.9A);None;None;MES L1217 ( 4.9A)","0.55A","5alcL-3zl4L:26.4","5alcL-3zl4L:94.91"],["5G0P_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","3zl4","A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN","Homo sapiens",4,"VAL L 108;ARG L  62;VAL L  18;GLU L  84","None","1.02A","5g0pA-3zl4L:undetectable;5g0pB-3zl4L:undetectable","5g0pA-3zl4L:19.53;5g0pB-3zl4L:19.53"],["5G0P_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","3zl4","A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN","Homo sapiens",4,"GLU L  84;VAL L 108;ARG L  62;VAL L  18","None","1.02A","5g0pA-3zl4L:undetectable;5g0pB-3zl4L:undetectable","5g0pA-3zl4L:19.53;5g0pB-3zl4L:19.53"]]